Article

External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population

2020-12-31

Abstract excerpt

<h4>Background: </h4> Initial results from various phase-III trials on vaccines against SARS-CoV-2 are promising. For proper translation of these results to clinical guidelines, it is essential to determine how well the general population is reflected in the study populations of these trials. <h4>Methods: </h4>: This study was conducted among 7162 participants (age-range: 51-106 years; 58% women) from the Rotterda...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a33d704b-bce9-5a0a-b5e9-84750db48aa0
DOI: 10.21203/rs.3.rs-137920/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European populationDOI 10.21203/rs.3.rs-137920/v1Read

Safety and Immunogenicity of an Inactivated Whole Virion SARS-CoV-2 Vaccine, TURKOVAC, in Healthy Adults: Interim Results from Randomised, Double-Blind, Placebo-Controlled Phase 1 and 2 TrialsSemantic proximity Read

STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE networkSemantic proximity Read

Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands – The VAccine Study COvid-19 (VASCO)Semantic proximity Read

A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2Semantic proximity Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in CanadaSemantic proximity Read

A Phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)Semantic proximity Read

Global, regional, and national estimates of target population sizes for COVID-19 vaccinationSemantic proximity Read

Global landscape of randomized controlled trials responding to the COVID-19 pandemic: a literature review protocolSemantic proximity Read

Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide surveySemantic proximity Read

Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in EnglandSemantic proximity Read

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European RegionSemantic proximity Read